Related Experiment Video
Updated: Jul 24, 2026

10:27
An Ultrasonic Tool for Nerve Conduction Block in Diabetic Rat Models
Published on: October 20, 2017
Parotid gland function in streptozotocin-diabetic rats
Journal of Dental Research
|February 1, 1987
Summary
Insulin directly impacts parotid gland function in diabetic rats, specifically restoring cholinergic stimulation responses. Diabetes alters parotid gland protein composition, but insulin treatment normalizes responses to methacholine.
Area of Science:
- Physiology
- Endocrinology
- Biochemistry
Background:
- Diabetes mellitus induces significant alterations in salivary gland function and protein composition.
- Parotid glands play a crucial role in saliva production, influenced by various neurochemical pathways.
Purpose of the Study:
- To investigate the in vivo effects of diabetes and insulin on parotid gland responses to adrenergic, cholinergic, and peptidergic agonists.
- To elucidate the specific mechanisms by which insulin modulates parotid gland acinar cell function in diabetic conditions.
Main Methods:
- Utilizing streptozotocin-induced diabetic rat models with varying durations and insulin treatments.
- Administering adrenergic (epinephrine), cholinergic (methacholine), and peptidergic (physalaemin) agonists to assess parotid gland responses.
- Analyzing parotid gland protein composition, including amylase and peroxidase concentrations.
Main Results:
- Diabetes significantly reduced the response to methacholine, which was restored by insulin treatment.
- Neither diabetes nor insulin affected the response to physalaemin.
- Diabetes altered parotid gland protein composition, decreasing amylase and increasing peroxidase.
- Epinephrine response thresholds were unaffected by diabetes, insulin, or diet modifications.
Conclusions:
- Insulin directly and specifically enhances the response of parotid acinar cells to cholinergic stimulation.
- The findings highlight a targeted role for insulin in regulating salivary gland function in diabetes.
- Parotid gland protein composition changes in diabetes are distinct from functional responses to specific agonists.

